Prospect Biosystems logo
cell culture
collection tubes
family doc
Prospect Biosystems engages in the development, manufacture, and marketing of bioanalytical instrumentation, reagents and a broad-range of biomarker applications to accelerate life sciences research; pharmaceutical development; clinical diagnostics; and surgical pathology.

Prospect’s EdgeTM Technology and its EDGE*TEST™ algorithm allow scientists, researchers, medical experts, including physicians and surgeons, involved in:

  • Analytical Proteomics to significantly enrich low-abundance proteins from their crude cell or tissue extracts;
  • Biomarker Discovery to rapidly characterize differences between diseased and healthy tissue;
  • Clinical Diagnostics to easily identify and evaluate predictive, diagnostic and prognostic disease biomarkers;
  • Surgical Pathology to facilitate outcome prediction through the use of tissue biomarkers, and;
  • Clinical Trials to accelerate and improve outcome prediction through the use of surrogate biomarkers.
  • Prospect…."the possibility of future success"

Partners with:
njit logo
©2010 Prospect Biosystems, Inc.